betamethasone has been researched along with 12-hydroxy-5,8,10,14-eicosatetraenoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barr, RM; Cunningham, FM; Greaves, MW; Mallet, AI; Mistry, K; Wong, E; Woollard, PM | 1 |
1 other study(ies) available for betamethasone and 12-hydroxy-5,8,10,14-eicosatetraenoic acid
| Article | Year |
|---|---|
Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Arachidonic Acid; Arachidonic Acids; Betamethasone; Clobetasol; Dinoprostone; Exudates and Transudates; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Male; Middle Aged; Prostaglandins E; Psoriasis; Skin | 1986 |